Cargando…

The Role of Advanced Practitioners in Optimizing Clinical Management and Support of Patients With Cytokine Release Syndrome From CAR T-Cell Therapy

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2019
Materias:	CE Information
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517763/ https://www.ncbi.nlm.nih.gov/pubmed/33425466

Ejemplares similares

Optimizing Treatment and Improving Outcomes for Patients With Acute Myeloid Leukemia: A Guide for Advanced Practitioners
Publicado: (2019)

Advances in HER2-Positive Breast Cancer: Novel Therapies and Adverse Event Management
Publicado: (2019)

The Role of Advanced Practitioners in Optimizing Clinical Management and Support of Patients With Cytokine Release Syndrome From CAR T-Cell Therapy
por: Adkins, Sherry
Publicado: (2019)

Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence
Publicado: (2020)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer
por: Tralongo, Antonino Carmelo, et al.
Publicado: (2022)

Use of ß-blocker therapy to prevent primary bleeding of esophageal varices
por: Tursi, Tammy
Publicado: (2010)

Deceased Organ Donor Management and Organ Distribution From Organ Procurement Organization-Based Recovery Facilities Versus Acute-Care Hospitals
por: Vail, Emily A., et al.
Publicado: (2023)

The Role of Advanced Practitioners in Optimizing Clinical Management and Support of Patients With Polycythemia Vera
por: Kurtin, Sandra, et al.
Publicado: (2018)

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, David, et al.
Publicado: (2018)

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
por: Wang, Zhenguang, et al.
Publicado: (2018)

Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
por: Ferreros, Puri, et al.
Publicado: (2022)

Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy
por: Balagopal, Srinivas, et al.
Publicado: (2022)

Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
por: Xiao, Xinyi, et al.
Publicado: (2021)

A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid?
por: Puccetti, Luca, et al.
Publicado: (2021)

Eating disorder symptomatology and substance use disorders: Prevalence and shared risk in a population based twin sample
por: Baker, Jessica H, et al.
Publicado: (2010)

Mediterranean Diet and Prevention of Chronic Diseases
por: Romagnolo, Donato F., et al.
Publicado: (2017)

What Is the Evidence Base for a Potassium Requirement?
por: Weaver, Connie M., et al.
Publicado: (2018)

Choline: The Underconsumed and Underappreciated Essential Nutrient
por: Wallace, Taylor C., et al.
Publicado: (2018)

Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019
por: Lazzeri, Chiara, et al.
Publicado: (2020)

Derivation of age-adjusted LACE index thresholds in the prediction of mortality and frequent hospital readmissions in adults
por: Fry, Christopher Henry, et al.
Publicado: (2020)

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
por: Polosa, Riccardo, et al.
Publicado: (2020)

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
por: Cameli, Paolo, et al.
Publicado: (2021)

Organ Transplantation Outcomes of Deceased Organ Donors in Organ Procurement Organization-Based Recovery Facilities Versus Acute-Care Hospitals
por: Vail, Emily A., et al.
Publicado: (2023)

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, D., et al.
Publicado: (2018)

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
por: Bandera, Alessandra, et al.
Publicado: (2021)

Separation of unsaturated C18 fatty acids using perfluorinated‐micellar electrokinetic chromatography: I. Optimization and separation process
por: Ta, Hai Yen, et al.
Publicado: (2022)

Cytokines Are at the Heart of It: Cytokine Release Syndrome Underlies Cardiovascular Effects of CAR T Cell
por: Catino, Anna B.
Publicado: (2020)

Camostat mesilate therapy for COVID-19
por: Uno, Yoshiharu
Publicado: (2020)

Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
por: Thakar, Monica S., et al.
Publicado: (2020)

Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome
por: Guo, Hanfei, et al.
Publicado: (2022)

A major role for CD4(+) T cells in driving cytokine release syndrome during CAR T cell therapy
por: Boulch, Morgane, et al.
Publicado: (2023)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment
por: Magon, Arianna, et al.
Publicado: (2021)

Role of doctors in epidemics: historical perspectives and implications for COVID-19
por: Lippi, Donatella, et al.
Publicado: (2020)

Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy
por: Moriyama, Shohei, et al.
Publicado: (2022)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
por: De Cauwer, Harald
Publicado: (2020)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies—reply
por: Albini, Adriana, et al.
Publicado: (2020)

Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy
por: Liu, Yanfen, et al.
Publicado: (2018)

Coexistence Of A Huge Venous Thromboembolism And Bleeding Tendency In Cytokine Release Syndrome During CAR-T Therapy
por: Liu, Haiyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_14dt0l25pe0l8rpqi90s9lp6tl